EUVIMEDEUVIMED entdecken
Open Access

Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP

Nazli Robin iD, Nicole G Barra iD, Kevin P Foley, Yujin E Li iD, Akhilesh K Tamrakar iD, Danish Patoli iD, Irena A Rebalka iD, Tabitha Cree iD, Kaitlyn Bibby, Khang Nguyen, Rhianna Davis, Darryl Y Chan iD und 13 weitere

Science Advances · 19.06.2026 · 12 (25)

DOI: 10.1126/sciadv.adz3612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 19.06.2026. Verfasst von Nazli Robin und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biomedical Sciences, McMaster University, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular Diseases, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council, National Health and Medical Research Council, Natural Science and Engineering Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statin intolerance and side effects such as low-level myopathy limit statin use and the dose for optimal cholesterol lowering. We found that priming the NLRP3 inflammasome with bacterial components like lipopolysaccharide lowered the dose of statins that caused side effects in muscle cells. We then built models of low-level statin myopathy and found that muscle cell–autonomous statin-induced myopathy occurs through the NLRP3 inflammasome in vitro and in mice. Statin-induced muscle cell death and higher Atrogin-1 were prevented by blocking NLRP3 or restoring isoprenoids but not cholesterol. Statins reduced glycolysis in muscle cells, which required lower protein prenylation. Statins lowered YAP effector genes and promoted nuclear accumulation of FOXO. Activating YAP, restoring isoprenoids, or blocking NLRP3 mitigated nuclear FOXO accumulation, statin-induced muscle atrophy, and statin-mediated lowering of protein synthesis. These results define a statin-induced myopathy pathway where metabolic danger engages the NLRP3 inflammasome and YAP via lower prenylation independent of cholesterol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinHydroxymethylglutaryl-CoA Reductase InhibitorsMuscular DiseasesAdaptor Proteins, Signal TransducingProtein PrenylationAnimalsMiceYAP-Signaling ProteinsInflammasomesMuscle, SkeletalCell Cycle ProteinsHumans

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinHydroxymethylglutaryl-CoA Reductase InhibitorsYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingInflammasomesNlrp3 protein, mouseYap1 protein, mouseCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Biomedical Sciences, McMaster University, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada.
  • Farncombe Family Digestive Health Research Institute, McMaster University, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada.
  • Centre for Metabolism, Obesity and Diabetes Research, McMaster University, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada.
  • Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow, India.
  • CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, F-69007, Lyon, France.
  • Department of Pathology and Molecular Medicine, McMaster University, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada.

ORCID-Profile: Nazli Robin, Nicole G Barra, Yujin E Li, Akhilesh K Tamrakar, Danish Patoli, Irena A Rebalka, Tabitha Cree, Darryl Y Chan, Megan E Borges, Dana Kukje Zada, Han Fang, Daniel M Marko, Paul Gregorevic, Kevin I Watt, Richard J Mills, Gary Sweeney, Thomas J Hawke, Bénédicte F Py, Jonathan D Schertzer

Förderung

  • European Research Council
  • National Health and Medical Research Council
  • Natural Science and Engineering Research Council
  • Novo Nordisk Foundation Center for Stem Cell Medicine

Zitieren

APA

Robin, N., Barra, N. G., Foley, K. P., Li, Y. E., Tamrakar, A. K., Patoli, D., Rebalka, I. A., Cree, T., Bibby, K., Nguyen, K., Davis, R., Chan, D. Y., Duggan, B. M., Henriksbo, B. D., Borges, M. E., Kukje Zada, D., Fang, H., Marko, D. M., Gregorevic, P., …, & Schertzer, J. D. (2026). Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP. Science Advances, 12(25). https://doi.org/10.1126/sciadv.adz3612

Vancouver

Robin N, Barra NG, Foley KP, Li YE, Tamrakar AK, Patoli D, et al. Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP. Science Advances. 2026;12(25). doi:10.1126/sciadv.adz3612

BibTeX
@article{Robin2026,
  author = {Robin, Nazli and Barra, Nicole G and Foley, Kevin P and Li, Yujin E and Tamrakar, Akhilesh K and Patoli, Danish and Rebalka, Irena A and Cree, Tabitha and Bibby, Kaitlyn and Nguyen, Khang and Davis, Rhianna and Chan, Darryl Y and Duggan, Brittany M and Henriksbo, Brandyn D and Borges, Megan E and Kukje Zada, Dana and Fang, Han and Marko, Daniel M and Gregorevic, Paul and Watt, Kevin I and Mills, Richard J and Sweeney, Gary and Hawke, Thomas J and Py, Bénédicte F and Schertzer, Jonathan D},
  title = {Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {25},
  doi = {10.1126/sciadv.adz3612}
}
Kostenlos starten →